180 related articles for article (PubMed ID: 38612731)
1. Metabolic Profiling as an Approach to Differentiate T-Cell Acute Lymphoblastic Leukemia Cell Lines Belonging to the Same Genetic Subgroup.
Alabed HBR; Pellegrino RM; Buratta S; Lema Fernandez AG; La Starza R; Urbanelli L; Mecucci C; Emiliani C; Gorello P
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612731
[TBL] [Abstract][Full Text] [Related]
2. Systems Approaches in the Common Metabolomics in Acute Lymphoblastic Leukemia and Rhabdomyosarcoma Cells: A Computational Approach.
C T; Zaravinos A; Tsartsalis AN; Tagka A; Kotoulas A; Geronikolou SA; Braoudaki M; Lambrou GI
Adv Exp Med Biol; 2021; 1338():55-66. PubMed ID: 34973010
[TBL] [Abstract][Full Text] [Related]
3. Investigation of deregulated genes of Notch signaling pathway in human T cell acute lymphoblastic leukemia cell lines and clinical samples.
Paryan M; Mohammadi-Yeganeh S; Samiee SM; Soleimani M; Arefian E; Azadmanesh K; Poopak B; Mostafavi E; Karimipoor M; Mahdian R
Mol Biol Rep; 2013 Oct; 40(10):5531-40. PubMed ID: 23982259
[TBL] [Abstract][Full Text] [Related]
4. MYB rearrangements and over-expression in T-cell acute lymphoblastic leukemia.
Bardelli V; Arniani S; Pierini V; Pierini T; Di Giacomo D; Gorello P; Moretti M; Pellanera F; Elia L; Vitale A; Storlazzi CT; Tolomeo D; Mastrodicasa E; Caniglia M; Chiaretti S; Ruggeri L; Roti G; Schwab C; Harrison CJ; Almeida A; Pieters T; Van Vlierberghe P; Mecucci C; La Starza R
Genes Chromosomes Cancer; 2021 Jul; 60(7):482-488. PubMed ID: 33611795
[TBL] [Abstract][Full Text] [Related]
5. T-Cell Acute Lymphoblastic Leukemia: Biomarkers and Their Clinical Usefulness.
Bardelli V; Arniani S; Pierini V; Di Giacomo D; Pierini T; Gorello P; Mecucci C; La Starza R
Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440292
[TBL] [Abstract][Full Text] [Related]
6. Design of a Comprehensive Fluorescence in Situ Hybridization Assay for Genetic Classification of T-Cell Acute Lymphoblastic Leukemia.
La Starza R; Pierini V; Pierini T; Nofrini V; Matteucci C; Arniani S; Moretti M; Lema Fernandez AG; Pellanera F; Di Giacomo D; Storlazzi TC; Vitale A; Gorello P; Sammarelli G; Roti G; Basso G; Chiaretti S; Foà R; Schwab C; Harrison CJ; Van Vlierberghe P; Mecucci C
J Mol Diagn; 2020 May; 22(5):629-639. PubMed ID: 32142900
[TBL] [Abstract][Full Text] [Related]
7. Deletions of the long arm of chromosome 5 define subgroups of T-cell acute lymphoblastic leukemia.
La Starza R; Barba G; Demeyer S; Pierini V; Di Giacomo D; Gianfelici V; Schwab C; Matteucci C; Vicente C; Cools J; Messina M; Crescenzi B; Chiaretti S; Foà R; Basso G; Harrison CJ; Mecucci C
Haematologica; 2016 Aug; 101(8):951-8. PubMed ID: 27151989
[TBL] [Abstract][Full Text] [Related]
8. [Effects of NANOG gene down-regulation on the apoptosis of T-cell acute lymphoblastic leukemia cells].
Cao J; Li L; Lyu C; Meng FJ; Zhou J; Chen C; Zeng LY; Li ZY; Xu KL
Zhonghua Xue Ye Xue Za Zhi; 2013 Dec; 34(12):1001-5. PubMed ID: 24369153
[TBL] [Abstract][Full Text] [Related]
9. MAP3K7 is recurrently deleted in pediatric T-lymphoblastic leukemia and affects cell proliferation independently of NF-κB.
Cordas Dos Santos DM; Eilers J; Sosa Vizcaino A; Orlova E; Zimmermann M; Stanulla M; Schrappe M; Börner K; Grimm D; Muckenthaler MU; Kulozik AE; Kunz JB
BMC Cancer; 2018 Jun; 18(1):663. PubMed ID: 29914415
[TBL] [Abstract][Full Text] [Related]
10. Senescent stromal cell-induced divergence and therapeutic resistance in T cell acute lymphoblastic leukemia/lymphoma.
Habiel DM; Krepostman N; Lilly M; Cavassani K; Coelho AL; Shibata T; Elenitoba-Johnson K; Hogaboam CM
Oncotarget; 2016 Dec; 7(50):83514-83529. PubMed ID: 27835864
[TBL] [Abstract][Full Text] [Related]
11. Biological activities of the lectin, abrin-a, against human lymphocytes and cultured leukemic cell lines.
Moriwaki S; Ohba H; Nakamura O; Sallay I; Suzuki M; Tsubouchi H; Yamasaki N; Itoh K
J Hematother Stem Cell Res; 2000 Feb; 9(1):47-53. PubMed ID: 10738971
[TBL] [Abstract][Full Text] [Related]
12. High-resolution genomic profiling of pediatric lymphoblastic lymphomas reveals subtle differences with pediatric acute lymphoblastic leukemias in the B-lineage.
Schraders M; van Reijmersdal SV; Kamping EJ; van Krieken JH; van Kessel AG; Groenen PJ; Hoogerbrugge PM; Kuiper RP
Cancer Genet Cytogenet; 2009 May; 191(1):27-33. PubMed ID: 19389505
[TBL] [Abstract][Full Text] [Related]
13. The Cooperative Anti-Neoplastic Activity of Polyphenolic Phytochemicals on Human T-Cell Acute Lymphoblastic Leukemia Cell Line MOLT-4 In Vitro.
Koszałka P; Stasiłojć G; Miękus-Purwin N; Niedźwiecki M; Purwin M; Grabowski S; Bączek T
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563141
[TBL] [Abstract][Full Text] [Related]
14. Deoxynucleotide-polymerizing enzyme activities in T- and B-cells of acute lymphoblastic leukemia origin.
Srivastava BI
Cancer Res; 1976 May; 36(5):1825-30. PubMed ID: 1083765
[TBL] [Abstract][Full Text] [Related]
15. A novel germline variant in PIK3R1 results in SHORT syndrome associated with TAL/LMO T-cell acute lymphoblastic leukemia.
Marzollo A; Maestrini G; La Starza R; Elia L; Malfona F; Pierini T; Tretti Parenzan C; Coppe A; Bortoluzzi S; Biffi A; Mecucci C; Bresolin S; Testi AM
Am J Hematol; 2020 Dec; 95(12):E335-E338. PubMed ID: 32936972
[No Abstract] [Full Text] [Related]
16. p53-independent epigenetic repression of the p21(WAF1) gene in T-cell acute lymphoblastic leukemia.
Davies C; Hogarth LA; Dietrich PA; Bachmann PS; Mackenzie KL; Hall AG; Lock RB
J Biol Chem; 2011 Oct; 286(43):37639-50. PubMed ID: 21903579
[TBL] [Abstract][Full Text] [Related]
17. A suppressor lymphokine produced by human T leukemia cell lines. Partial characterization and spectrum of activity against normal and malignant hemopoietic cells.
Santoli D; Tweardy DJ; Ferrero D; Kreider BL; Rovera G
J Exp Med; 1986 Jan; 163(1):18-40. PubMed ID: 2416868
[TBL] [Abstract][Full Text] [Related]
18. Polycomb repressor complex 2 regulates HOXA9 and HOXA10, activating ID2 in NK/T-cell lines.
Nagel S; Venturini L; Marquez VE; Meyer C; Kaufmann M; Scherr M; MacLeod RA; Drexler HG
Mol Cancer; 2010 Jun; 9():151. PubMed ID: 20565746
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of type I insulin-like growth factor receptor tyrosine kinase by picropodophyllin induces apoptosis and cell cycle arrest in T lymphoblastic leukemia/lymphoma.
Huang Z; Fang Z; Zhen H; Zhou L; Amin HM; Shi P
Leuk Lymphoma; 2014 Aug; 55(8):1876-83. PubMed ID: 24206093
[TBL] [Abstract][Full Text] [Related]
20. Induction of human malignant T-lymphoblastic cell lines MOLT-3 and jurkat by 12-O-tetradecanoylphorbol-13-acetate: biochemical, physical, and morphological characterization.
Nagasawa K; Howatson A; Mak TW
J Cell Physiol; 1981 Oct; 109(1):181-92. PubMed ID: 6976970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
